To assess the viability, 1 × 104 cells in 96‐well flat‐bottom plates were treated with increasing concentrations of Trametinib or TRAIL as indicated for 72 hours. To each well, 20 μL of 5 mg/mL MTT reagent (Roche, Basel, Switzerland) was added, and the plates were incubated for 1 hour in the tissue culture incubator at 37°C. The crystals of formazan were solubilized with 150 μL DMSO after the media were removed. The absorbance at 450 nm was determined by microplate reader.
Do you have any questions about this protocol?
Post your question to gather feedback from the community. We will also invite the authors of this article to respond.